The Hypoxia-Inducible Factor 2 α N-Terminal and C-Terminal Transactivation Domains Cooperate To Promote Renal Tumorigenesis In Vivo
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor, consisting of an alpha subunit and a beta subunit, that controls cellular responses to hypoxia. HIFalpha contains two transcriptional activation domains called the N-terminal transactivation domain (NTAD) and the C-terminal transactivation domain (CTAD). HIFalpha is destabilized by prolyl hydroxylation catalyzed by EglN family members. In addition, CTAD function is inhibited by asparagine hydroxylation catalyzed by FIH1. Both hydroxylation reactions are linked to oxygen availability. The von Hippel-Lindau tumor suppressor protein (pVHL) is frequently mutated in kidney cancer and is part of the ubiquitin ligase complex that targets prolyl hydroxylated HIFalpha for destruction. Recent studies suggest that HIF2alpha plays an especially important role in promoting tumor formation by pVHL-defective renal carcinoma cells among the three HIFalpha paralogs. Here we dissected the relative contribution of the two HIF2alpha transactivation domains to hypoxic gene activation and renal carcinogenesis and investigated the regulation of the HIF2alpha CTAD by FIH1. We found that the HIF2alpha NTAD is capable of activating both artificial and naturally occurring HIF-responsive promoters in the absence of the CTAD. Moreover, we found that the HIF2alpha CTAD, in contrast to the HIF1alpha CTAD, is relatively resistant to the inhibitory effects of FIH1 under normoxic conditions and that, perhaps as a result, both the NTAD and CTAD cooperate to promote renal carcinogenesis in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, HIF2α is relatively resistant to FIH1-mediated inactivation compared to HIF1α (Bracken et al., 2006; Yan et al., 2007).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Yan et al., 2007
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 2×
“Most solid tumors contain hypoxic regions in which HIF is stabilized and active, as determined by the induction of HIF target genes that promote survival in a hypoxia environment (18).”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“786-O renal carcinoma cell subclones stably transfected with pRc-CMV-HA-VHL (WT7) ( 27 ) were grown in DMEM containing 10% fetal clone I (HyClone) containing 1 mg/ml G418 in a 37°C, 10% CO2 incubator.”
MethodEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · cited 1×
“These genes include genes that control angiogenesis (such as vascular endothelial growth factor [VEGF]), energy metabolism (for example, the glucose transporter 1 [GLUT1] and carbonic anhydrase IX [CAIX]), erythropoiesis (such as erythropoietin [EPO]), and mitogenesis (for example, transforming growth factor and plate…”
BackgroundRegulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 1×
“HIF (hypoxia-inducible factor) is a master transcriptional regulator of hypoxia-inducible genes and is composed of the subunit HIF1, or one of its paralogs HIF2 or HIF3, and a HIF subunit, such as HIF1 (also called the aryl hydrocarbon receptor nuclear translocator [ARNT]) (12, 14, 17, 20, 50 , 53).”
BackgroundHIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558 · cited 4×
“Mutation of the relevant hydroxylation sites renders these GAL4 fusions constitutively active and insensitive to oxygen (19, 36, 37 ).”
BackgroundInfluentialLando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550 · cited 8×
“Like the EglN prolyl hydroxylases, FIH1 is an Fe(II) and 2-oxoglutarate-dependent dioxygenase, and its activity can be blocked with competitive inhibitors of 2-oxoglutarate and with iron chelators (19, 36).”
BackgroundInfluential
Cited by
Items 101–193 of 193
Bnip3 and AIF cooperate to induce apoptosis and cavitation during epithelial morphogenesis
Qi, Y., Tian, X., Liu, J., Han, Y., Graham, A. M., Simon, M. C., Penninger, J. M., Carmeliet, P., & Li, S. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201111063 · Cited by 44
“Mutant human HIF-1 PP and HIF-2 PPN in the pBabe-puro vector were obtained from Addgene (Yan et al., 2007).”
MethodFonseca, J., Moradi, F., Maddalena, L. G., Tollstadius, B. F., Selim, S., & Stuart, J. A. (2018) · Oncology Letters · doi:10.3892/ol.2018.9526 · Cited by 35
Macklin, P. S., Yamamoto, A., Browning, L., Hofer, M., Adam, J., & Pugh, C. W. (2020) · The Journal of Pathology · doi:10.1002/path.5402 · Cited by 35
FGF 11 induced by hypoxia interacts with HIF ‐1α and enhances its stability
Lee, K. W., Yim, H., Shin, J., Lee, C., Lee, J., & Jeong, J. (2016) · FEBS Letters · doi:10.1002/1873-3468.12547 · Cited by 38
“The pcDNA3-HA-HIF-1, pcDNA3-HA-HIF1a P402A/P564A and pGL2-HRE-luciferase were gifts from William Kaelin (Addgene plasmid # 18949, #18955) and Navdeep Chandel (Addgene plasmid # 26731), respectively [19-21].”
MethodReactivation of Epstein-Barr Virus by HIF-1α Requires p53
Kraus, R. J., Cordes, B.-L. A., Sathiamoorthi, S., Patel, P., Yuan, X., Iempridee, T., Yu, X., Lee, D. L., Lambert, P. F., & Mertz, J. E. (2020) · Journal of Virology · doi:10.1128/jvi.00722-20 · Cited by 35
“Plasmid pcDNA3HA-HIF-1 P402A/P564A-pcDNA3 expresses an amino-terminal hemagglutinin (HA)-tagged, oxygen-insensitive variant of HIF-1 (68); it was obtained from William Kaelin via Addgene (18955).”
MethodLysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
Punnia-Moorthy, G., Hersey, P., Emran, A. A., & Tiffen, J. C. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.680633 · Cited by 33
Madaris, T. R., Venkatesan, M., Maity, S., Stein, M. C., Vishnu, N., Venkateswaran, M. K., Davis, J. G., Ramachandran, K., Uthayabalan, S., Allen, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112155 · Cited by 30
Li, Z., Ding, L., Ma, R., Zhang, Y., Zhang, Y., Ni, W., Tang, T., Wang, G., Wang, B., Lv, L., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05854-5 · Cited by 31
“Meanwhile, convincing evidence has revealed that HIF CTAD knockout has no impact on the HIF-dependent transcriptional activation function [28].”
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology
Shirole, N. H., & Kaelin, W. G. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2023.04.011 · Cited by 39
Self-citationAstrocyte pVHL and HIF-α isoforms are required for embryonic-to-adult vascular transition in the eye
Kurihara, T., Westenskow, P. D., Krohne, T. U., Aguilar, E., Johnson, R. S., & Friedlander, M. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201107029 · Cited by 32
“DNA constructs for HA–HIF-1 P402A/P564A (CA–Hif-1) and HA–Hif-2 P405A/P531A (CA–Hif-2) were deposited by W.G. Kaelin (plasmids 18955 and 18956; Addgene; Yan et al., 2007). pMaxGFP (Lonza) was cotransfected to label transfected cells in some experiments.”
BackgroundMethodHIF1-alpha expressing cells induce a hypoxic-like response in neighbouring cancer cells
Harrison, H., Pegg, H. J., Thompson, J. L., Bates, C., & Shore, P. (2018) · BMC Cancer · doi:10.1186/s12885-018-4577-1 · Cited by 34
Yasui, T., Uezono, N., Nakashima, H., Noguchi, H., Matsuda, T., Andoh-Noda, T., Okano, H., & Nakashima, K. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.001 · Cited by 33
“However, the expression of a constitutively active form of HIF1a (HIF1a-CA) (Yan et al., 2007), to mimic the hypoxic situation in the cells, synergistically induced astrocytic differentiation of AF22 with NICD under normoxia even in the absence of exogenous LIF (Figures 4D and 4E).”
BackgroundQi, Y., Liu, X. J., Saadat, S., Tian, X., Han, Y., Fong, G.-H., Pandolfi, P. P., Lee, L. Y., & Li, S. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.185 · Cited by 31
“The pcDNA3-myr-HA-Akt1 vector, encoding and a myristoylated, constitutively active Akt1 and pBabe-puro HIF-2α PPN, were obtained from Addgene.(44,45) The construction of the Bnip3 expression vector was described previously.”
MethodDavid, J. M., Owens, T. A., Inge, L. J., Bremner, R. M., & Rajasekaran, A. K. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0891 · Cited by 31
Alánová, P., Alán, L., Opletalová, B., Bohuslavová, R., Abaffy, P., Matějková, K., Holzerová, K., Benák, D., Kaludercic, N., Menabò, R., et al. (2024) · Acta Physiologica · doi:10.1111/apha.14202 · Cited by 32
Gupta-Saraf, P., & Miller, C. L. (2014) · Oncotarget · doi:10.18632/oncotarget.1767 · Cited by 28
“pHA-HIF-1α [Addgene plasmid 18949, [61]] and pHA-HIF-1α P402A/P564A [Addgene plasmid 18955, [62]] were obtained from Dr.”
Jin, X., Gong, L., Peng, Y., Li, L., & Liu, G. (2021) · Aging · doi:10.18632/aging.202137 · Cited by 24
“The HIF-1α (P402A/P564A) is constitutively active due to its nondegradable feature [43].”
BackgroundSelf-citationHypoxia-induced CTCF promotes EMT in breast cancer
Kakani, P., Dhamdhere, S. G., Pant, D., Joshi, R., Mishra, J., Samaiya, A., & Shukla, S. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114367 · Cited by 29
Mittal, K., Choi, D. H., Ogden, A., Donthamsetty, S., Melton, B. D., Gupta, M. V., Pannu, V., Cantuaria, G. H., Varambally, S., Reid, M. D., et al. (2017) · Scientific Reports · doi:10.1038/srep43984 · Cited by 26
Suppression of Glioma Progression by Egln3
Sciorra, V. A., Sanchez, M. A., Kunibe, A., & Wurmser, A. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040053 · Cited by 26
Molecular targets on the horizon for kidney and urothelial cancer
Bellmunt, J., Teh, B. T., Tortora, G., & Rosenberg, J. E. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.155 · Cited by 26
Non-viral gene delivery of HIF-1α promotes angiogenesis in human adipose-derived stem cells
Est-Witte, S. E., Farris, A. L., Tzeng, S. Y., Hutton, D. L., Gong, D. H., Calabresi, K. G., Grayson, W. L., & Green, J. J. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.06.042 · Cited by 25
Toth, R. K., Tran, J. D., Muldong, M. T., Nollet, E. A., Schulz, V. V., Jensen, C., Hazelhurst, L. A., Corey, E., Durden, D. L., Jamieson, C., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/685602 · Cited by 28
“[54] Yan Q, Bartz S, Mao M, Li L and Kaelin WG Jr.”
Araki, D., Fu, J., Huntsman, H. D., Cordes, S., Seifuddin, F., Alvarado, L. J., Cheruku, P. S., Cash, A., Traba, J., Li, Y., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.08.001 · Cited by 25
“To determine whether the impact of hypoxia on NOTCH signaling was linked to the specific recruitment of HIF-1a, we measured HES-1 expression in CD34 cells transduced with a lentiviral vector expressing a mutant HIF-1a (P402A/P564A) known to resist proteasome degradation (Yan et al., 2007), and cultured these cells und…”
MethodPradhan, S. N., Mahajan, D., Kaur, P., Pandey, N., Sharma, C., & Srivastava, T. (2016) · Oncotarget · doi:10.18632/oncotarget.12378 · Cited by 21
“The HIF1α mutant coding plasmid- HA-HIF1alpha P402A/P564A-pcDNA3 was gifted by William Kaelin [29] (#18955).”
MethodFujii, M., Kawashima, N., Tazawa, K., Hashimoto, K., Nara, K., Noda, S., Kuramoto, M., Orikasa, S., Nagai, S., & Okiji, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.032 · Cited by 22
Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas
Taïeb, D., Barlier, A., Yang, C., Pertuit, M., Tchoghandjian, A., Rochette, C., Zattara-Canoni, H., Figarella‐Branger, D., Zhuang, Z., Pacák, K., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1983-y · Cited by 21
“the relative contributions of the C-TAD and N-TAD of HIF-2a to target gene activation in ccRCC lines indicates that the C-TAD is largely dispensable for transcriptional activation by HIF-2a [31].”
BackgroundIriondo, O., Mecenas, D., Li, Y., Chin, C. R., Thomas, A., Moriarty, A., Marker, R., Wang, Y. J., Hendrick, H., Amzaleg, Y., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2028 · Cited by 21
Sabharwal, S. S., Dudley, V. J., Landwerlin, C., & Schumacker, P. T. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104624 · Cited by 18
“Retroviral vectors encoding nondegradable forms of either HIF1α or HIF2α (26) were obtained from Addgene (HAHIF1alpha-P402A/564A-pBABE-puro and HA-HIF2alphaP405A/P531A-pBABE-puro (Addgene plasmids # 19005 and # 19006).”
MethodInfluentialRenal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved
Shanmugasundaram, K., & Block, K. L. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6569 · Cited by 22
Hypoxia promotes airway differentiation in the human lung epithelium
Dong, Z., Wit, N., Agarwal, A., Reid, A. J., Dubal, D., Beier, S., Mahbubani, K. T. A., Saeb‐Parsy, K., van den Ameele, J., Nathan, J. A., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.09.007 · Cited by 21
Yue, Y., Tang, Y., Huang, H., Zheng, D., Liu, C., Zhang, H., Liu, Y., Li, Y., Sun, X., & Lu, L. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104829 · Cited by 21
“HA-HIF1alpha P402A/P564A-pBabe-puro and HAHIF2alpha-P405A/P531A-pBabe-puro were gifts from William Kaelin (Addgene plasmid #19005; #19006) (47).”
MethodEvagelou, S. L., Bebenek, O., Specker, E. J., & Uniacke, J. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00610-19 · Cited by 22
“The HA–HIF- vectors produce stable nondegradable proteins that can be expressed in normoxia and retain their function (54).”
BackgroundHypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers
Horst, B., Pradhan, S. N., Chaudhary, R., Listik, E., Quintero-Macías, L., Choi, A. S., Southard, M., Liu, Y., Whitaker, R. S., Hempel, N., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03495-6 · Cited by 18
Hoefflin, R., Harlander, S., Abhari, B. A., Peighambari, A., Adlesic, M., Seidel, P., Zodel, K., Haug, S., Göçmen, B., Li, Y., et al. (2021) · Cancers · doi:10.3390/cancers13194801 · Cited by 16
“A gatekeeper G323E mutation was introduced into the HA-HIF2α wt-pBabePuro plasmid [27] using the QuikChange II XL mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA) and confirmed by Sanger sequencing.”
MethodWinning, S., & Fandrey, J. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0004 · Cited by 16
“HIF-1 a is more sensitive to FIH-1-mediated inactivation compared with HIF-2 a (10, 104).”
Piasecka, D., Braun, M., Mieszkowska, M., Kowalczyk, L., Kopczyński, J., Kordek, R., Sądej, R., & Romańska, H. (2020) · Neoplasia · doi:10.1016/j.neo.2020.09.003 · Cited by 17
Endothelial PPARδ facilitates the post-ischemic vascular repair through interaction with HIF1α
Wu, Y., Tang, X., Lee, S., Hong, H., Cao, X., Lau, C. W., Liu, B., Chawla, A., Ronald, C. W., Huang, Y., et al. (2022) · Theranostics · doi:10.7150/thno.69017 · Cited by 15
“net/addgene:18955; RRID: Addgene_ 18955) were gifts from William Kaelin [24].”
MethodCheng, B., Ma, X.-S., Zhou, Y., Liu, J., Fei, X., Pan, W., Peng, X., Wang, W., & Chen, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116645 · Cited by 19
Fujii, M., Kawashima, N., Tazawa, K., Hashimoto, K., Nara, K., Noda, S., Nagai, S., & Okiji, T. (2020) · International Endodontic Journal · doi:10.1111/iej.13264 · Cited by 18
Romaschin, A. D., Youssef, Y., Chow, T.-F. F., Siu, K. W. M., DeSouza, L. V., Honey, R. J. D., Stewart, R., Pace, K. T., & Yousef, G. M. (2008) · Biological Chemistry · doi:10.1515/bc.2009.013 · Cited by 16
Manipulation of neural progenitor fate through the oxygen sensing pathway
Xie, Y., & Lowry, W. E. (2017) · Methods · doi:10.1016/j.ymeth.2017.08.018 · Cited by 16
“Mutating those residues to alanine, such as P564A [54], P577A/P402A [56], P577A/P402A/N813A [57], P402A/P564A in HIF1α, and P530A/P405A [56], P405A/P531A [58] in HIF2α, disables the VHL targeted degradation of HIF protein, and thus stabilizes HIF protein under atmospheric oxygen.”
BackgroundBouthelier, A., Meléndez‐Rodríguez, F., Urrutia, A. A., & Aragonés, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249401 · Cited by 14
Zhu, J., Jiang, X., & Chehab, F. F. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m043521 · Cited by 19
Deficiency in PHD2-mediated hydroxylation of HIF2α underlies Pacak-Zhuang syndrome
Ferens, F. G., Taber, C. C., Stuart, S. E., Hubert, M., Tarade, D., Lee, J. E., & Ohh, M. (2024) · Communications Biology · doi:10.1038/s42003-024-05904-4 · Cited by 14
“…(D539N, A530V, P531A, Y532C) and Class 2 (M535T, G537R, P534R, Y532H) HIF2 α mutants, as well as mutant P405A, were generated using QuikChange site-directed mutagenesis (Agilent) and con fi rmed by DNA sequencing. pcDNA3-HA-HIF2 α -P405A/P531A was obtained from Addgene (Addgene plasmid # 18956) 29 .”
MethodMallet, C., Cochard, J., Leclercq, S., Trapp-Fragnet, L., Chouteau, P., & Denesvre, C. (2021) · Journal of Virology · doi:10.1128/jvi.01427-21 · Cited by 14
“net/addgene:87261]; RRID:Addgene_87261) is a CMV promoter-driven vector expressing stabilized HIF-1a in which the three amino acids targeted by hydroxylation were mutated (67).”
BackgroundThe transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia
Magliulo, D., Simoni, M., Caserta, C., Fracassi, C., Belluschi, S., Giannetti, K., Pini, R., Zapparoli, E., Beretta, S., Uggé, M., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317810 · Cited by 12
“Cells were incubated overnight with concentrated virus (MOI = 20), and then transplanted into NSG recipient mice within 24 h from bone marrow isolation.”
MethodLee, M.-C., Huang, H.-J., Chang, T.-H., Huang, H.-C., Hsieh, S.-Y., Chen, Y.-S., Chou, W.-Y., Chiang, C.-H., Lai, C.-H., & Shiau, C.-Y. (2016) · Scientific Reports · doi:10.1038/srep29311 · Cited by 12
HIF-2α drives an intrinsic vulnerability to ferroptosis in clear cell renal cell carcinomaPreprint
Zou, Y., Palte, M. J., Deik, A., Li, H., Eaton, J. K., Wang, W., Tseng, Y., Deasy, R., Alimova, M., Dančík, V., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/388041 · Cited by 11
“Finally, transiently overexpressing HIF prolyl hydroxylase (PHD)-resistant, constitutively active HIF-2αP405A/P531A and HIF-2αP405A/P531A/N847A variants in HK-2 cells increased sensitivity to GPX4 inhibition (Figure S3O) [65].”
BackgroundQin, L., Chung, Y., Berk, M. P., Naelitz, B. D., Zhu, Z., Klein, E. A., Chakraborty, A. A., & Sharifi, N. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4256 · Cited by 13
Celada, L., Cubiella, T., San‐Juan‐Guardado, J., Martínez, A. S. J., Valdés, N., Jiménez‐Fonseca, P., Díaz, I., Enguita, J. M., Astudillo, A., Álvarez-González, E., et al. (2022) · Cancers · doi:10.3390/cancers14122986 · Cited by 12
“Transient transfections with pBabe-puro as control or HAHIF2alpha-P405A/P531A-pBabe-puro, a gift from William Kaelin [62] (Harvard Medical School, Boston, MA, USA), were performed with Lipofectamine LTX (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s protocol, at a final concentration of 2.”
MethodInfluentialDNA writing at a single genomic site enables lineage tracing and analog recording in mammalian cellsPreprint
Loveless, T. B., Grotts, J. H., Schechter, M. W., Forouzmand, E., Carlson, C. K., Agahi, B. S., Liang, G., Ficht, M., Liu, B., Xie, X. S., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/639120 · Cited by 9
Rosell-García, T., Rivas-Muñoz, S., Kin, K., Romero-Albillo, V., Alcaraz, M., Fernández‐Tornero, C., & Rodríguez‐Pascual, F. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194963 · Cited by 13
Prevention of apoptosis by the interaction between FIH1 and Bax
Yan, B., Kong, M., & Chen, Y. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0631-2 · Cited by 8
Hypoxia, ROS, and HIF Signaling in I/R Injury: Implications and Future Prospects
Singh, M. K., Yun, H. R., Ranbhise, J. S., Han, S., Kim, S. S., & Kang, I. (2026) · Antioxidants · doi:10.3390/antiox15020153 · Cited by 11
“Notably, HIF-2 α is more resistant to hydroxylation by FIH-1 than HIF-1 α , suggesting that there are isoform-specific activation thresholds and differential utilization of the CTAD [65,66].”
RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling
Niu, Z., Fan, J., Chen, F., Yang, H., Li, X., Zhuang, T., Guo, C., Cao, Q., Zhu, J., Wang, H., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05473-6 · Cited by 8
Decoupling NAD+ metabolic dependency in chondrosarcoma by targeting the SIRT1-HIF-2α axis
Suh, J., Kim, H., Min, J., Yeon, H. J., Hemberg, M., Scimeca, L., Wu, M.-R., Kang, H. G., Kim, Y., & Kim, J. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101342 · Cited by 9
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
Stampone, E., Bencivenga, D., Capellupo, M. C., Roberti, D., Tartaglione, I., Perrotta, S., Ragione, F. D., & Borriello, A. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04852-2 · Cited by 9
Sodium vitamin C transporter 2 orchestrates lactate metabolism in mouse Sertoli cells
Gao, G., Zhao, Y., Wang, K., & Wang, F. (2020) · Journal of Molecular Endocrinology · doi:10.1530/jme-20-0101 · Cited by 6
HIF2 Regulates Intestinal Wnt5a Expression
García, C. J. G., Acevedo-Diaz, A., Kumari, N., Govindaraju, S., Bonilla, M. D. L. C., Lucas, F. A. S., Nguyen, N. D., Jiménez-Sacarello, I., Piwnica-Worms, H. M., Maitra, A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.769385 · Cited by 5
Hammarlund, E. U., Bukkuri, A., Norling, M. D., Islam, M., Posth, N. R., Baratchart, E., Carroll, C., Amend, S. R., Gatenby, R. A., Pienta, K. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57345-0 · Cited by 6
“Based on how FIH, CTAD, NTAD and the prolines are known to differentially register and respond to O 2 fl uctuations 54 – 56 , cellular oxygen-sensing mechanisms appears be becomere fi ned between Placozoa and Cnidaria,between Cnidaria and Bilateria and especially within Bilateria (compare e.g. variants within Protostomi…”
InfluentialKlinger, P., Schietke, R. E., Warnecke, C., Swoboda, B., Wiesener, M. S., Hennig, F. F., & Gelse, K. (2011) · Transcription · doi:10.4161/trns.2.6.18619 · Cited by 5
“activity, s nce a fun tionally important N-terminal transactivation domain (NTAD) was identified within the ODD domain.(9,15) Therefore, the aim of this study was to directly compare the transcriptional activity of HIF1α/HIF2α mutants lacking the complete ODD domain (HIF1αΔODD and HIF2αΔODD) to HIF1α/HIF2α mutants in…”
BackgroundBai, X., Kawashima, N., Wang, S., Han, P., Fujii, M., Nara, K., Yu, Z., Okiji, T., & Yahata, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210837 · Cited by 3
Makulyte, G., Safwan‐Zaiter, H., Goehrig, D., Huna, A., Mangelinck, A., Mikawa, T., Palazzo, A., Moudombi, L., Médard, J., Chanal, M., et al. (2025) · Aging Cell · doi:10.1111/acel.70307 · Cited by 3
Pandey, N., Chongtham, J., Pal, S., Ali, A., Lalwani, S., Jain, D., Mohan, A., & Srivastava, T. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119302 · Cited by 2
Molecular Biology of Clear Cell Renal Carcinoma
Kaelin, W. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_2 · Cited by 2
Self-citationYuan, J., Maitra, S., Antoniou, E., Zhu, J., Li, W., Demirel, I. S., Toskas, K., Martinez, I. L., Ozcimen, L., Lindehell, H., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2516922122 · Cited by 1
“To address this, we utilized the piggyBac transposon system (33) to overexpress a stabilized version of HIF2 α (34) under the control of doxycycline ( iHIF2 α ) (Fig.”
Progress and challenges in the development of advanced pancreatic cancer organoids
Detert, K., Piotrowsky, A., Marongiu, L., Leischner, C., Lauer, U. M., Venturelli, S., & Burkard, M. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03717-3 · Cited by 2
THE VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN AND KIDNEY CANCER
Kaelin, W. G., & Ma, B. (2007) · Medicina-buenos Aires · Cited by 1
Self-citationHypoxic memory of tumor intrinsic type I interferon suppression promotes breast cancer metastasisPreprint
Iriondo, O., Mecenas, D., Li, Y., Chin, C. R., Thomas, A., Amzaleg, Y., Moriarty, A., Ortiz, V., MacKay, M. J., Dickerson, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.12.491632 · Cited by 1
Platelets and Anti-Angiogenic Resistance in Ovarian Carcinoma
Bottsford-Miller, J. N. (2012) · Digital Commons-TMC (Texas Medical Center)
Transcriptional Regulation by Hypoxia-Inducible Factors in Tumor Cells
Löfstedt, T. (2007) · Lund University Publications (Lund University)
Gossage, L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_4 · Cited by 2
Novel strategies for nephroprotection using hypoxia-inducible gene expression
Warnecke, C., Bernhardt, W., Willam, C., Wiesener, M. S., & Eckardt, K. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2007.07.002
Mechanisms of chronic complications of diabetes with focus on mitochondria and oxygen sensing
Savu, I. O. (2009) · Figshare
EPAS1 Promotes Endothelial Cell Migration in an IRX3-Dependent Manner
Woodruff, R. W., & Barnett, P. (2016)
The Biological Role of Factor-Inhibiting Hypoxia- Inducible Factor
Khan, M. N. (2008) · Spiral (Imperial College London) · doi:10.25560/4645
A Novel Role for Tid1 in HIF2α Regulation
Burnett, D. (2010) · TSpace (University of Toronto)
Role of Hypoxia-inducible Factor in Kidney Cancer
Roberts, A. M. (2012) · TSpace (University of Toronto)
Zhao, F. L. (2014) · UA Campus Repository (The University of Arizona)
Fonseca, J. (2019) · Brock University Digital Repository (Brock University)
Prevention of apoptosis by the interaction between FIH1 and Bax
YanMen, B., & Chen, K.-H. (2011)
Pandey, N., Chongtham, J., Pal, S., Mohan, A., & Srivastava, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.08.459287
Couteaudier, M., Nivard, M., Cochard, J., Mammano, F., Roingeard, P., de ROCQUIGNY, H., & Chouteau, P. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05739-0
Li, S., Zhang, B.-W., Wei, Z.-J., Xi, Y., Zhang, G.-A., Zhang, Y., Kou, D.-C., Song, X.-P., Huang, J., Song, P., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05983-4
“…of the HIF1α and HIF2α mutants, HIF1α-P402A/P564A and HIF2α-P405A/P531A, whose prolyl hydroxylation sites were mutated, allowing both HIF1α [13, 14 ] and HIF2α [ 15, 16] to be stabilized in HeLa cells under normoxic conditions, also had no obvious effect on β-TrCP1 protein levels (Fig.”
Avinery, L., Regev, D., Khamaisi, H., Gopas, J., & Mahajna, J. A. (2026) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2025.106240
Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression
Fabbri, L. (2019) · theses.fr (ABES) · doi:10.70675/7a53239dzc652z4ea4z8b95z4a71961c83b4
Gregor, T., Karakaya, S., Zethraeus, A., Ostenberg, S., Fredlund, E., Hammarlund, E. U., Hansson, J., Rosenblum, J., & Mohlin, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.04.722697
“Nonetheless, our findings converge in showing that combined deletion of NTAD and CTAD does not fully abolish HRE promoter activation ( 41 ), suggesting the presence of an additional, cryptic transactivation site.”
LAMTOR2 Reprograms Energy Metabolism to Sustain Hepatocellular Carcinoma Cell Survival
Xiao, J., Fan, D., 吴印兵, Cao, X., Yang, Z., Li, H., 鍾文彬, Li, M., & Yan, D. (2026) · The FASEB Journal · doi:10.1096/fj.202602088r
“To achieve constitutively active expression of HIF1α, a site-directed mutagenesis strategy was employed to introduce the P402A and P564A mutations into the human HIF1α coding sequence [26, 27].”
Metadata
- Authors
- Yan, Q., Bartz, S., Mao, M., Li, L., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Rosetta Inpharmatics, LLC.
- Corresponding author
- Kaelin, William G.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-03-01
- Volume
- 27
- Issue
- 6
- Pages
- 2092-2102
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1820491
- OpenAlex
- W2161071327
- Cited by
- 193
- References
- 58
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 5 · 2023: 10 · 2022: 11 · 2021: 10 · 2020: 14 · 2019: 19 · 2018: 6 · 2017: 9 · 2016: 12 · 2015: 7 · 2014: 11 · 2013: 14 · 2012: 9
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Dana-Farber/Harvard Cancer Center
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- HIF-2α, hypoxia-inducible factor, N-terminal transactivation domain, C-terminal transactivation domain, renal carcinogenesis, kidney cancer, VHL, prolyl hydroxylation, transcriptional activation, hypoxia
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Amino Acid Sequence, Animals, Cell Line, Cell Transformation, Neoplastic, Humans, Kidney Neoplasms, Mice, Nude, Molecular Sequence Data, Mutation, Transcriptional Activation, Sequence Alignment, Conserved Sequence, Xenograft Model Antitumor Assays, Cell Proliferation, Mice, Rats, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.